Hunt Nimrata's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Aug 8, 2025
- Accession no.
- 0000874716-25-000127
- Filed
- Aug 8, 2025
- Trade date
- Aug 6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hunt NimrataCIK 0001800619 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +1,218 | $141.60 | +$172,468.8 | 13,573.94 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +5,865 | $178.26 | +$1,045,494.9 | 19,438.94 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseAcquired | +5,711 | $206.94 | +$1,181,834.34 | 25,149.94 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −3,018 | $629.87 | −$1,900,947.66 | 22,131.94 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −2,907 | $630.91F2 | −$1,834,055.37 | 19,224.94 | Direct | |
| Aug 6, 2025 | Common Stock | SSaleDisposed | −1,218 | $630.69 | −$768,180.42 | 18,006.94 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −1,218 | $0.00 | $0 | 0 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −5,865 | $0.00 | $0 | 0 | Direct | |
| Aug 6, 2025 | Common Stock | MOption exerciseDisposed | −5,711 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold ranging from a low of $630.50 to a high of $630.94 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.